A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/29/2011	US8067446 Methods for treating an ulcer of the small intestine and stomach
11/29/2011	US8067445 N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
11/29/2011	US8067444 Administering to a diabetic patient with a baseline serum creatinine concentration of =/>1.3 mg/dL an amount of pyridoxamine or its chloride to limit renal disease progression and/or diabetic complications to slow the increase in serum creatinine levels in the patient relative to placebo; ACE inhibitors
11/29/2011	US8067443 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
11/29/2011	US8067442 Heterocyclic antiviral compounds
11/29/2011	US8067441 Use of collismycin and derivatives thereof as oxidative stress inhibitors
11/29/2011	US8067440 Phosphonium salts derivatives and uses thereof
11/29/2011	US8067439 Biphenyl compounds useful as muscarinic receptor antagonists
11/29/2011	US8067438 Hepatitis C inhibitor compounds
11/29/2011	US8067437 Beta-2-adrenoreceptor agonists
11/29/2011	US8067436 c-Met modulators and methods of use
11/29/2011	US8067434 Compounds and methods for development of Ret modulators
11/29/2011	US8067433 Methods, compositions, and kits for the treatment of ophthalmic disorders
11/29/2011	US8067432 Liposomal, ring-opened camptothecins with prolonged, site-specific delivery of active drug to solid tumors
11/29/2011	US8067431 Chemically modified small molecules
11/29/2011	US8067430 Anti-HIV activity of the opioid antagonist naloxone
11/29/2011	US8067429 Forms of rifaximin and uses thereof
11/29/2011	US8067428 Platelet ADP receptor inhibitors
11/29/2011	US8067427 Pharmaceutical compositions comprising ZD6474
11/29/2011	US8067426 6-amino-purin-8-one compounds
11/29/2011	US8067425 Neuroprotective bicyclic compounds and methods for their use
11/29/2011	US8067420 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods
11/29/2011	US8067419 N-[(S)-1-benzyl-2-(4-benzyl-piperazin-1-yl)-2-oxo-ethyl]-N-(4-pentyl-benzyl)-3-(4-trifluoromethyl-phenyl)-acrylamide, for example; antiprotozoa agents
11/29/2011	US8067418 Tricyclic angiotensin II agonists
11/29/2011	US8067417 Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases
11/29/2011	US8067416 Methods and compositions for the treatment of metabolic disorders
11/29/2011	US8067415 Compounds useful as antagonists of CCR2
11/29/2011	US8067414 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
11/29/2011	US8067413 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
11/29/2011	US8067412 analogs of natural products radicicol and pochonins; (oxirane or cyclopropan) 2-benzoxacyclo(di)tetradecin derivatives; inhibition of kinase phosphorylation activity and heat shock proteins; anticarcinogenic, antiinflammatory agent; neurodegenerative diseases; antiallergen
11/29/2011	US8067411 Compounds
11/29/2011	US8067410 Phenolic and catecholic amines and prodrugs thereof
11/29/2011	US8067409 Protein kinase inhibitors
11/29/2011	US8067408 Dual pharmacophores—PDE4-muscarinic antagonistics
11/29/2011	US8067407 Substituted dihydropyrazolones and their use
11/29/2011	US8067406 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
11/29/2011	US8067405 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
11/29/2011	US8067404 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
11/29/2011	US8067403 Methods and systems for preparing an antimicrobial composition
11/29/2011	US8067402 Applying to an oral surface (teeth or gums)one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning; dentistry; bonding agents, resin cements, sealants
11/29/2011	US8067401 Compounds and compositions for treating infection
11/29/2011	US8067400 Improving embryo score; administering to human female; harvesting, fertilization of oocytes and forming embryos; adjust concentration of prasterone
11/29/2011	US8067399 Method and apparatus for transdermal or transmucosal application of testosterone
11/29/2011	US8067397 Transdiscal administration of cycline compounds
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067395 Inhibitors of tyrosine kinases and uses thereof
11/29/2011	US8067394 Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
11/29/2011	US8067393 Sugar-immobilized metal nanoparticle, method for measuring sugar-protein interaction using the same and method for recovering protein from sugar-protein interactant
11/29/2011	US8067392 Compositions and methods for treatment of mitochondrial diseases
11/29/2011	US8067391 ODCase inhibitors for the treatment of malaria
11/29/2011	US8067390 Therapeutic targeting of interleukins using siRNA in neutral liposomes
11/29/2011	US8067389 Silencing of TGFβ type II receptor expression by siRNA
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067386 Modulation of eIF4E-BP2 expression
11/29/2011	US8067385 Antiviral oligonucleotides targeting HBV
11/29/2011	US8067383 Synthetic genes and genetic constructs comprising same I
11/29/2011	US8067381 Methods and compositions for increasing the anaerobic working capacity in tissues
11/29/2011	US8067359 Diabetic therapy; mixture of proteins, fats and carbohydrates
11/29/2011	US8067358 Triple-action remedy for removing toxic oils from skin with simultaneous soothing and healing
11/29/2011	US8067356 High fibre high calorie liquid or powdered nutritional composition
11/29/2011	US8067228 Nucleic acid compositions and their use against the hepatitic C virus
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067189 Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV
11/29/2011	US8067180 Using mitogen activated kinase as tool in identifying modulators for treatment and prevention of cell proliferative disorders
11/29/2011	US8067156 From adeno-associated virus; for treatment of acute conditions requiring rapid gene expression
11/29/2011	US8067041 Method for treatment of constipation-predominant irritable bowel syndrome
11/29/2011	US8067037 Trehalose-containing topical drying composition and method of using same
11/29/2011	US8067033 Stable compositions of famotidine and ibuprofen
11/29/2011	US8067032 Method for preparing submicron particles of antineoplastic agents
11/29/2011	US8067031 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
11/29/2011	US8067022 Therapeutic inhibitor of vascular smooth muscle cells
11/29/2011	US8067010 Immunological herpes simplex virus antigens and methods for use thereof
11/29/2011	US8067007 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	US8067000 Cancer treatment with endothelin receptor antagonists
11/29/2011	US8066978 Biopolymer and gene complex
11/29/2011	US8066976 Foaming compositions for hair care
11/29/2011	US8066975 Psoriasis or seborrheic dermatitis; mixture of clobetasol propionate, an anionic surfactant (sodium lauryl ether sulfate), an amphoteric surfactant ( cocamidopropyl betaines); a propenetrating agent chosen from ethanol, isopropanol, propylene glycol and ethoxydiglycol; foam with good compactnes; shampoo
11/29/2011	US8066971 Targeting pulmonary epithelium using ADRP
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2661334C Pyrimidone compounds as gsk-3 inhibitors
11/29/2011	CA2658359C Heterocyclic compounds and methods of use
11/29/2011	CA2650248C Compounds and compositions as hedgehog pathway modulators
11/29/2011	CA2641581C Stabilization of solid thyroid drug formulations
11/29/2011	CA2636826C Thiazoles as 11 beta-hsd1 inhibitors
11/29/2011	CA2631724C Improved oral compositions comprising zinc citrate and/or tocopherol agents
11/29/2011	CA2621066C Method for treatment or prevention of conditions caused by gram-positive bacteria
11/29/2011	CA2614647C Osmotic device containing venlafaxine and an anti-psychotic agent
11/29/2011	CA2613417C Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
11/29/2011	CA2611520C Method and composition for pharmaceutical product
11/29/2011	CA2593427C Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/29/2011	CA2579032C Use of an .delta.-amino acid as thymocyte growth agent
11/29/2011	CA2571055C Compounds and methods for treating seizure and paroxysmal disorders
11/29/2011	CA2569739C Antitumor effect potentiator, antitumor preparation, and method for treating cancer
11/29/2011	CA2541470C Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors
11/29/2011	CA2526022C Sulfotransferase inhibitor
11/29/2011	CA2525657C Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
11/29/2011	CA2522535C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2011	CA2519797C Low molecular weight hyaluronic acid for the treatment of nerve damage
11/29/2011	CA2519733C Indazole having analgesic activity

1 ... 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 ... 7860